SCHEMBL19976757

SCHEMBL19976757

CC(C)(C)CN/C(=N/C(=O)c1ccc(F)c(F)c1)Nc1n[nH]c2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.39
MAPK10 P53779 8/20 0.39
MAPK8 P45983 6/20 0.39
ABL1 P00519 1/20 0.38
BCR P11274 1/20 0.38
GSK3B P49841 6/20 0.37
DAPK3 O43293 2/20 0.37
PRKD3 O94806 2/20 0.37
MAP4K4 O95819 2/20 0.37
PIM1 P11309 2/20 0.37
CDK2 P24941 2/20 0.37
CDK8 P49336 2/20 0.37
CLK2 P49760 2/20 0.37
CDK5 Q00535 2/20 0.37
MAP4K2 Q12851 2/20 0.37
DYRK1A Q13627 2/20 0.37
MAP4K5 Q9Y4K4 2/20 0.37
PLK4 O00444 1/20 0.37
MAPK13 O15264 1/20 0.37
CDK1 P06493 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19976730 0.87 HDAC6 (0.41) HDAC6MAPK10MAPK8GSK3BDAPK3
SCHEMBL19976800 0.87 GSK3B (0.43) HDAC6MAPK10MAPK8GSK3BDAPK3
SCHEMBL19976846 0.87 KDM4E (0.42) HDAC6MAPK10MAPK8ABL1BCR
SCHEMBL19976731 0.85 MAPK1 (0.42) HDAC6MAPK8ABL1BCRGSK3B
SCHEMBL19976886 0.83 GSK3B (0.43) HDAC6GSK3BGSK3ACYP1A2
SCHEMBL19976734 0.82 MAPK10 (0.36) HDAC6MAPK10MAPK8ABL1BCR
SCHEMBL19976888 0.81 GSK3B (0.51) HDAC6MAPK10MAPK8GSK3BMAPKAPK5
SCHEMBL19976875 0.81 HDAC6 (0.35) HDAC6ABL1BCRGSK3BFLT4
SCHEMBL18558427 0.79 KCNQ3 (0.35) ABL1BCR
SCHEMBL19976765 0.77 NTRK1 (0.41) HDAC6MAPK8GSK3BDAPK3PRKD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9920012-B2 Indazole guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-20 US disclosed